• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射双氢麦角胺(DHE)治疗难治性偏头痛的最新评估:患者选择与特殊考量

Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations.

作者信息

Shafqat Rafia, Flores-Montanez Yadira, Delbono Victoria, Nahas Stephanie J

机构信息

Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.

出版信息

J Pain Res. 2020 Apr 30;13:859-864. doi: 10.2147/JPR.S203650. eCollection 2020.

DOI:10.2147/JPR.S203650
PMID:32431533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7200221/
Abstract

Dihydroergotamine (DHE) is an ergot alkaloid derivative of substances produced by rye fungus. Ergotamine was first used in the field of gynecology and obstetrics, then used for migraine treatment a few years later. DHE was developed as a derivative of ergotamine. DHE, when compared to ergotamine, demonstrates greater alpha-adrenergic antagonist activity, lower arterial vasoconstriction, less dopaminergic agonism, and lower emetic potential. DHE can be delivered via several routes including intravenous (IV), intramuscular (IM), subcutaneous (SC), intranasal (IN), oral, and orally inhaled (although the latter two are not available in the USA and the last remains experimental only). DHE can be used in an outpatient basis in infusion centers, emergency departments, and urgent care centers, as well as inpatient treatment for admitted patients. There are protocols for adults as well as pediatric migraine treatment. DHE and other ergot alkaloids are considered contraindicated in pregnant women as they decrease uterine blood flow and increase uterine muscle contractility predisposing to spontaneous abortion. DHE during lactation is also not recommended as it can lead to gastrointestinal distress and weakness in infants; it can also suppress milk production. Caution should be taken before administering DHE in patients with cardiovascular risk factors. DHE is an older drug with an interesting history, yet it is still clinically useful today for patients with migraine attacks not responsive to triptans, who have a greater burden from migraine, and in refractory migraine.

摘要

双氢麦角胺(DHE)是一种由黑麦真菌产生的物质的麦角生物碱衍生物。麦角胺最初用于妇产科领域,几年后用于偏头痛治疗。DHE是作为麦角胺的衍生物开发的。与麦角胺相比,DHE表现出更强的α-肾上腺素能拮抗剂活性、更低的动脉血管收缩作用、更少的多巴胺能激动作用和更低的致吐潜力。DHE可以通过多种途径给药,包括静脉内(IV)、肌内(IM)、皮下(SC)、鼻内(IN)、口服和口服吸入(尽管后两种在美国不可用,最后一种仅处于实验阶段)。DHE可用于输液中心、急诊科和紧急护理中心的门诊治疗,以及住院患者的住院治疗。有针对成人和儿童偏头痛治疗的方案。DHE和其他麦角生物碱被认为在孕妇中禁用,因为它们会减少子宫血流量并增加子宫肌肉收缩力,易导致自然流产。哺乳期也不建议使用DHE,因为它会导致婴儿胃肠道不适和虚弱;还会抑制乳汁分泌。对于有心血管危险因素的患者,在使用DHE之前应谨慎。DHE是一种历史悠久的药物,然而,对于对曲坦类药物无反应、偏头痛负担更大的偏头痛患者以及难治性偏头痛患者,它在当今临床上仍然有用。

相似文献

1
Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations.静脉注射双氢麦角胺(DHE)治疗难治性偏头痛的最新评估:患者选择与特殊考量
J Pain Res. 2020 Apr 30;13:859-864. doi: 10.2147/JPR.S203650. eCollection 2020.
2
The 5-HT and 5-HT agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans.5-羟色胺及5-羟色胺激动剂在急性偏头痛治疗中的应用:麦角胺、双氢麦角胺及曲坦类药物。
Handb Clin Neurol. 2024;199:17-42. doi: 10.1016/B978-0-12-823357-3.00008-2.
3
The pharmacology of ergotamine and dihydroergotamine.麦角胺和双氢麦角胺的药理学
Headache. 1997;37 Suppl 1:S15-25.
4
Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine.甲磺酸二氢麦角胺经精密嗅觉给药(INP104)治疗偏头痛急性发作的心血管安全性。
Headache. 2024 Sep;64(8):983-994. doi: 10.1111/head.14669. Epub 2024 May 27.
5
Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine.二氢麦角胺:用于治疗偏头痛急性发作的制剂方法综述。
CNS Drugs. 2013 May;27(5):385-94. doi: 10.1007/s40263-013-0061-2.
6
Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.双氢麦角胺的药理学及其在偏头痛治疗中的有效性和安全性证据。
Headache. 2006 Nov;46 Suppl 4:S171-81. doi: 10.1111/j.1526-4610.2006.00601.x.
7
Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine: current perspectives.酒石酸麦角胺和双氢麦角胺在偏头痛治疗中的合理应用:当前观点
Headache. 1997;37 Suppl 1:S42-5.
8
Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children.儿童难治性偏头痛静脉注射双氢麦角胺方案的实施
Headache. 2020 Sep;60(8):1653-1663. doi: 10.1111/head.13937. Epub 2020 Aug 27.
9
Orally inhaled dihydroergotamine: a review.口服二氢麦角胺:综述。
Headache. 2013 Sep;53 Suppl 2:43-53. doi: 10.1111/head.12184.
10
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.1906年及以后麦角胺和双氢麦角胺在偏头痛治疗中的应用历史。
Cephalalgia. 2008 Aug;28(8):877-86. doi: 10.1111/j.1468-2982.2008.01578.x. Epub 2008 May 5.

引用本文的文献

1
Migraine treatment amid intravenous fluid shortages.静脉输液短缺情况下的偏头痛治疗
Brain Circ. 2025 May 31;11(2):159-161. doi: 10.4103/bc.bc_6_25. eCollection 2025 Apr-Jun.
2
Tolerability of repetitive dihydroergotamine infusions paired with an adjustment in preventive treatment strategy in chronic headache disorders in children and youth.儿童和青少年慢性头痛疾病中重复双氢麦角胺输注的耐受性与预防性治疗策略调整的配对研究
J Headache Pain. 2025 Apr 30;26(1):93. doi: 10.1186/s10194-025-02035-x.
3
Migraine and Its Treatment from the Medicinal Chemistry Perspective.从药物化学角度看偏头痛及其治疗
ACS Pharmacol Transl Sci. 2024 Mar 16;7(4):951-966. doi: 10.1021/acsptsci.3c00370. eCollection 2024 Apr 12.
4
Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine.打破循环:揭示难治性偏头痛的诊断、病理生理及治疗挑战
Front Neurol. 2023 Sep 27;14:1263535. doi: 10.3389/fneur.2023.1263535. eCollection 2023.
5
Brachial Artery Vasospasm From Sequential Use of Intravenous Promethazine and Dihydroergotamine for Treatment of Status Migrainosus: A Case Report.静脉序贯使用异丙嗪和双氢麦角胺治疗偏头痛持续状态导致肱动脉血管痉挛:一例报告
Neurohospitalist. 2023 Apr;13(2):196-199. doi: 10.1177/19418744231153478. Epub 2023 Mar 23.
6
Study of the Mechanisms and Therapeutic Approaches of Migraine in Women and Pregnancy: A Literature Review.女性偏头痛与妊娠的发病机制及治疗方法研究:文献综述
Cureus. 2023 Feb 21;15(2):e35284. doi: 10.7759/cureus.35284. eCollection 2023 Feb.
7
Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies.观察性分析使用预防性治疗药物的医疗补助计划患者急性突破性偏头痛发作相关治疗费用。
Adv Ther. 2023 Mar;40(3):1141-1152. doi: 10.1007/s12325-022-02386-w. Epub 2023 Jan 17.

本文引用的文献

1
Enhancing Outpatient Dihydroergotamine Infusion With Interdisciplinary Care to Treat Refractory Pediatric Migraine: Preliminary Outcomes From the Comprehensive Aggressive Migraine Protocol ("CAMP").增强门诊二氢麦角胺输注的多学科护理以治疗难治性小儿偏头痛:综合强化偏头痛方案(“CAMP”)的初步结果。
Headache. 2020 Jan;60(1):101-109. doi: 10.1111/head.13685. Epub 2019 Oct 18.
2
Epidemiology and Treatment of Menstrual Migraine and Migraine During Pregnancy and Lactation: A Narrative Review.月经性偏头痛和妊娠及哺乳期偏头痛的流行病学和治疗:一项叙述性综述。
Headache. 2020 Jan;60(1):200-216. doi: 10.1111/head.13665. Epub 2019 Oct 3.
3
The Global Burden of Headache.全球头痛负担。
Semin Neurol. 2018 Apr;38(2):182-190. doi: 10.1055/s-0038-1646946. Epub 2018 May 23.
4
Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment.静脉血栓形成率增加可能与住院患者使用双氢麦角胺治疗有关。
Neurology. 2017 Jul 18;89(3):279-283. doi: 10.1212/WNL.0000000000004108. Epub 2017 Jun 14.
5
Outcome and Cost of Inpatient Hospitalization for Intravenous Dihydroergotamine Treatment of Refractory Pediatric Headache.静脉注射双氢麦角胺治疗难治性小儿头痛的住院治疗结果及费用
Pediatr Neurol. 2017 Jan;66:76-81. doi: 10.1016/j.pediatrneurol.2016.09.009. Epub 2016 Sep 19.
6
Management of Adults With Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies.急诊科成人急性偏头痛管理:美国头痛学会肠外药物治疗的证据评估。
Headache. 2016 Jun;56(6):911-40. doi: 10.1111/head.12835.
7
Acute Treatment Therapies for Pediatric Migraine: A Qualitative Systematic Review.儿科偏头痛的急性治疗疗法:定性系统评价。
Headache. 2016 Jan;56(1):49-70. doi: 10.1111/head.12746.
8
Inpatient management of migraine.偏头痛的住院治疗
Curr Neurol Neurosci Rep. 2015 Apr;15(4):13. doi: 10.1007/s11910-015-0539-z.
9
Treatment of pediatric migraine.小儿偏头痛的治疗。
Curr Treat Options Neurol. 2015 Jan;17(1):326. doi: 10.1007/s11940-014-0326-1.
10
Dihydroergotamine and sumatriptan in isolated human coronary artery, middle meningeal artery and saphenous vein.双氢麦角胺与舒马曲坦对离体人冠状动脉、脑膜中动脉及大隐静脉的作用
Cephalalgia. 2015 Feb;35(2):182-9. doi: 10.1177/0333102414544977. Epub 2014 Jul 30.